Membership Directory

AVEO Pharmaceuticals, Inc.

Category: Drug Development
Phone: 617-299-5000
Fax: 617-995-4995
Website: http://www.aveopharma.com

AVEO employs powerful, proprietary genetic model systems to discover and develop drugs against essential targets critical to the origin, maintenance and spread of malignant tumors. This novel high-throughput in vivo technology platform enables the rapid functional identification and prioritization of only the most relevant drug targets – dramatically improving the efficiency of drug discovery. Additionally, by identifying patient populations likely to be responsive to drug therapy, AVEO’s technology enables smarter drug development, decreased development costs and improved attrition. Founded in 2002, the Company has raised approximately $60M in two rounds of financing from leading life science investors: Flagship Ventures, Greylock Partners, Highland Capital Partners, MPM Capital, Lotus Biosciences, Oxford Bioscience Partners, Prospect Ventures, Venrock Associates, as well as several private investors. Partnering is central to AVEO’s business model. As a private company with a committed blue-chip life sciences investor base, world-class advisors, an industry-experienced management team, and a broadly applicable technology platform, AVEO is uniquely positioned to be creative in its approach to collaborations and in-licensing to eventually develop and commercialize its own drugs.

Back to list

Recent Jobs